Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-04-14Clinical Trial Update: "SEVERE ASTHMA" in the COMMUNITY
A brief update on a clinical trial related to severe asthma sponsored by Meir Medical Center; the study status is currently unknown.
-
CLINICAL_TRIALS withdrawal · 2015-04-13Clinical Trial Update: Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma [Phase 3]
A Phase 3 clinical trial evaluating NVA237 for poorly controlled asthma has been withdrawn.
-
FDA approval · 2015-04-13FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved Triamcinolone Acetonide via an Original Application (ANDA) for Padagis Israel Pharmaceuticals Ltd., authorizing a generic corti…
-
CLINICAL_TRIALS withdrawal · 2015-04-10Clinical Trial Update: A Clinical Trial Evaluating the Safety and Effectiveness of Golimumab in Patients With Severe, Persistent Asthma [Phase 2]
A Phase 2 trial evaluating the safety and effectiveness of golimumab in patients with severe, persistent asthma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: Anti-histamines and Methacholine Challenges. [Phase 4]
Phase 4 clinical trial update indicating completion of a study evaluating anti-histamines and methacholine challenges in asthma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2015-04-06Clinical Trial Update: Acid-suppressing Drugs Pregnancy Asthma Offspring Study
Clinical trial update indicating completion of a study on acid-suppressing drugs during pregnancy and potential asthma in offspring.
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children [Phase 2]
A Phase 2 dose-ranging trial of vilanterol inhalation powder for asthma in children has completed, with results posted.
-
CLINICAL_TRIALS research · 2015-04-03Clinical Trial Update: Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis [Phase 4]
Phase 4 clinical trial update on extra-fine formoterol/beclomethasone for asthmatic crises conducted by the National Institute of Respirator…
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen [Phase 2]
A Phase 2 trial evaluating the efficacy of AZD5423 in mild asthma patients challenged with an inhaled allergen has completed, with results p…
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: Asthma in Central Texas Project [NA]
A completed clinical trial sponsored by the University of Texas at Austin evaluated asthma. The results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Feasibility of an ED Initiated Online Asthma Management Program for Urban Teens [NA]
A completed study evaluating the feasibility of an emergency department-initiated online asthma management program for urban teens. The tria…
-
FDA approval · 2015-03-31FDA Approved: PROAIR DIGIHALER — Original Application (Teva Respiratory, LLC)
FDA approved PROAIR DIGIHALER (albuterol sulfate) from Teva Respiratory under an Original Application, introducing a digital inhaler version…
-
CLINICAL_TRIALS trial_result · 2015-03-31Clinical Trial Update: Fine Particle pMDI Formoterol/Beclomethasone in Asthmatics With and Without Spacer: Comparative Efficacy Evaluation [Phase 3]
Phase 3 trial evaluating the efficacy of a fine-particle pMDI inhaler containing formoterol/beclomethasone in asthmatics, comparing use with…
-
CLINICAL_TRIALS research · 2015-03-27Clinical Trial Update: WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction
Clinical trial WEUKBRE5554 from IMI PROTECT Work Package 2 reports on beta2 agonists and acute myocardial infarction; the study sponsored by…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: The Use of Exhaled Nitric Oxide in Conjunction With the Asthma Control Test to Determine Asthma Control in Pediatric Patients
A pediatric asthma study evaluating exhaled nitric oxide in combination with the Asthma Control Test was terminated. The termination indicat…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma [Phase 2]
Circassia Limited announced the completion of its Grass-SPIRE Phase 2 trial in subjects with seasonal allergic rhinitis and asthma. The stud…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy [Phase 3]
Phase 3 trial evaluating omalizumab in patients with moderate-to-severe persistent allergic asthma not adequately controlled on GINA Step 4 …
-
FDA approval · 2015-03-20FDA Approved: FLUTICASONE FUROATE ELLIPTA — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories for Fluticasone furoate Ellipta, enabling a generic version of the inha…
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: Kinetics of IgE Memory B Cells, Plasmablasts and Plasma Cells After Whole Lung Allergen Challenge in Mild Asthmatics [NA]
Clinical trial update on the kinetics of IgE memory B cells, plasmablasts, and plasma cells following a whole-lung allergen challenge in ind…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: FeNO After Hypoxia in Asthma Patients [NA]
Clinical trial evaluating FeNO response after hypoxia in asthma patients has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Prevention Allergic Disease of Infant With Probiotics During Pregnancy and Neonatal Period [Phase 3]
Phase 3 trial evaluating whether maternal and neonatal probiotics prevent allergic diseases in infants; the study (NCT00325273) is completed…
-
FDA approval · 2015-03-16FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s supplemental application for Montelukast Sodium.
-
FDA approval · 2015-03-12FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for XOPENEX HFA (levalbuterol tartrate) from Lupin Pharmaceuticals, approving changes to the product…
-
FDA approval · 2015-03-12FDA Approved: MONTELUKAST SODIUM — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved Montelukast Sodium from Macleods Pharmaceuticals Limited under an Original Application (ANDA 203582).
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects [Phase 2]
Phase 2 trial evaluating MagniXene MRI to assess regional lung function by delineating ventilation defects in patients with asthma and chron…